DR. ROLAND CLEMENT BLANTZ, MD
Osteopathic Medicine in San Diego, CA
License number
California C34211
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California C34211
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
2
200 W W Arbor Dr Mail Code: 9111-H, San Diego, CA 92103
13050 Via Grimaldi, Del Mar, CA 92014
13050 Via Grimaldi, Del Mar, CA 92014
Phone
(858) 552-7528
(858) 552-7549 (Fax)
(858) 794-9953
(858) 552-7549 (Fax)
(858) 794-9953
Personal information
See more information about ROLAND CLEMENT BLANTZ at radaris.comName
Address
Phone
140 Camarillo Ave, Oxnard, CA 93035
13050 Via Grimaldi, Del Mar, CA 92014
Professional information
See more information about ROLAND CLEMENT BLANTZ at trustoria.com
Professor And Head Nephrology-Hypertension At University Of California, San Diego, School Of Medicine
Professor And Head Nephrology-Hypertension At University Of California, San Diego, School Of Medicine
Position:
Professor and Head Nephrology-Hypertension at University of California, San Diego, School of Medicine
Location:
Greater San Diego Area
Industry:
Research
Work:
University of California, San Diego, School of Medicine
-
Professor and Head Nephrology-Hypertension
Roland Clement Blantz, San Diego CA
Roland Clement Blantz, San Diego CA
Specialties:
Internal Medicine, Nephrology
Work:
Urgentcare San Diego Medical Center
200 W Arbor Dr, San Diego, CA 92103 Va San Diego Healthcare System
3350 La Jolla Village Dr, San Diego, CA 92161 Urgentcare San Diego Thornton Hospital
9300 Campus Point Dr, La Jolla, CA 92037
200 W Arbor Dr, San Diego, CA 92103 Va San Diego Healthcare System
3350 La Jolla Village Dr, San Diego, CA 92161 Urgentcare San Diego Thornton Hospital
9300 Campus Point Dr, La Jolla, CA 92037
Education:
Johns Hopkins University (1965)
Roland Clement Blantz, San Diego CA
Roland Clement Blantz, San Diego CA
Specialties:
Nephrologist
Address:
200 W Arbor Dr, San Diego, CA 92103
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine
University Health System - Fellowship - Family Medicine
University of Colorado Hospital-Anschutz Inpatient Pavilion - Residency - Family Medicine
University Health System - Fellowship - Family Medicine
University of Colorado Hospital-Anschutz Inpatient Pavilion - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)
Dr. Roland C Blantz - MD (Doctor of Medicine)
Dr. Roland C Blantz - MD (Doctor of Medicine)
Hospitals:
200 W Arbor Dr, San Diego 92103
200 W Arbor Dr, San Diego 92103
200 W Arbor Dr, San Diego 92103
Education:
Medical Schools
Johns Hopkins University School Of Medicine
Graduated: 1965
Johns Hopkins University School Of Medicine
Graduated: 1965
Method Of Improved Diuresis In Individuals With Impaired Renal Function
Method Of Improved Diuresis In Individuals With Impaired Renal Function
US Patent:
2006003, Feb 16, 2006
Filed:
Oct 11, 2005
Appl. No.:
11/248905
Inventors:
Kenneth Widder - Rancho Santa Fe CA, US
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Scott Thomson - Poway CA, US
Roland Blantz - Del Mar CA, US
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Scott Thomson - Poway CA, US
Roland Blantz - Del Mar CA, US
International Classification:
A61K 31/549, A61K 31/522
US Classification:
514263320, 514223500
Abstract:
Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
Method Of Improved Diuresis In Individuals With Impaired Renal Function
Method Of Improved Diuresis In Individuals With Impaired Renal Function
US Patent:
2006003, Feb 9, 2006
Filed:
Oct 11, 2005
Appl. No.:
11/248479
Inventors:
Kenneth Widder - Rancho Santa Fe CA, US
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Scott Thomson - Poway CA, US
Roland Blantz - Del Mar CA, US
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Scott Thomson - Poway CA, US
Roland Blantz - Del Mar CA, US
International Classification:
A61K 31/549, A61K 31/522
US Classification:
514263320, 514223500
Abstract:
Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
Method Of Improved Diuresis In Individuals With Impaired Renal Function
Method Of Improved Diuresis In Individuals With Impaired Renal Function
US Patent:
2005000, Jan 6, 2005
Filed:
Apr 23, 2004
Appl. No.:
10/830617
Inventors:
Kenneth Widder - Rancho Santa Fe CA, US
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Scott Thomson - Poway CA, US
Roland Blantz - Del Mar CA, US
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Scott Thomson - Poway CA, US
Roland Blantz - Del Mar CA, US
International Classification:
A61K031/522, A61K031/405
US Classification:
514263300
Abstract:
Disclosed is a pharmaceutical composition comprising a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, and a non-adenosine modifying diuretic. Also disclosed are methods of inducing a diuretic effect in an animal comprising the step of administering a therapeutically effective amount of KW-3902, or a salt, ester, amide, metabolite, or prodrug thereof, in combination with second pharmaceutical composition capable of inducing a diuretic effect.
Method Of Treatment Of Disease Using An Adenosine A1 Receptor Antagonist
Method Of Treatment Of Disease Using An Adenosine A1 Receptor Antagonist
US Patent:
2004022, Nov 18, 2004
Filed:
Feb 23, 2004
Appl. No.:
10/785446
Inventors:
Lauren Otsuki - San Diego CA, US
Howard Dittrich - San Diego CA, US
Kenneth Widder - Rancho Santa Fe CA, US
Roland Blantz - Del Mar CA, US
Scott Thomson - Poway CA, US
Howard Dittrich - San Diego CA, US
Kenneth Widder - Rancho Santa Fe CA, US
Roland Blantz - Del Mar CA, US
Scott Thomson - Poway CA, US
International Classification:
A61K031/4745, A61K031/4184, A61K031/401, A61K031/137
US Classification:
514/303000, 514/381000, 514/651000, 514/423000
Abstract:
Disclosed are pharmaceutical composition comprising a beta-blocker and an adenosine Areceptor antagonist (AARA), an angiotensin converting enzyme (ACE) inhibitor and an adenosine Areceptor antagonist (AARA), and an angiotensin II receptor blocker (ARB) and an adenosine Areceptor antagonist (AARA). Also disclosed are methods of treating cardiovascular disease, renal disease, alkalosis, or diabetic nephropathy comprising identifying a patient in need of such treatment, and administering a pharmaceutical composition disclosed herein to said patient.